MMIRF
Price
$0.05
Change
-$0.04 (-44.44%)
Updated
Oct 3 closing price
Capitalization
33.35M
Intraday BUY SELL Signals
TECX
Price
$23.20
Change
+$0.25 (+1.09%)
Updated
Feb 4, 03:15 PM (EDT)
Capitalization
428.6M
Intraday BUY SELL Signals
Interact to see
Advertisement

MMIRF vs TECX

Header iconMMIRF vs TECX Comparison
Open Charts MMIRF vs TECXBanner chart's image
Medmira
Price$0.05
Change-$0.04 (-44.44%)
Volume$10K
Capitalization33.35M
Tectonic Therapeutic
Price$23.20
Change+$0.25 (+1.09%)
Volume$200
Capitalization428.6M
MMIRF vs TECX Comparison Chart in %
MMIRF
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
MMIRF vs. TECX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MMIRF is a Buy and TECX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (MMIRF: $0.01 vs. TECX: $22.94)
Brand notoriety: MMIRF and TECX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MMIRF: 32% vs. TECX: 196%
Market capitalization -- MMIRF: $33.35M vs. TECX: $428.6M
MMIRF [@Biotechnology] is valued at $33.35M. TECX’s [@Biotechnology] market capitalization is $428.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MMIRF’s FA Score shows that 1 FA rating(s) are green whileTECX’s FA Score has 0 green FA rating(s).

  • MMIRF’s FA Score: 1 green, 4 red.
  • TECX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MMIRF and TECX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MMIRF’s TA Score shows that 4 TA indicator(s) are bullish while TECX’s TA Score has 6 bullish TA indicator(s).

  • MMIRF’s TA Score: 4 bullish, 3 bearish.
  • TECX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TECX is a better buy in the short-term than MMIRF.

Price Growth

MMIRF (@Biotechnology) experienced а +10.83% price change this week, while TECX (@Biotechnology) price change was +12.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TECX($429M) has a higher market cap than MMIRF($33.4M). MMIRF YTD gains are higher at: 10.833 vs. TECX (9.971). MMIRF has higher annual earnings (EBITDA): -2.67M vs. TECX (-64.7M). TECX has more cash in the bank: 268M vs. MMIRF (0). TECX has less debt than MMIRF: TECX (1.24M) vs MMIRF (9.57M). MMIRF has higher revenues than TECX: MMIRF (233K) vs TECX (0).
MMIRFTECXMMIRF / TECX
Capitalization33.4M429M8%
EBITDA-2.67M-64.7M4%
Gain YTD10.8339.971109%
P/E RatioN/A4.59-
Revenue233K0-
Total Cash0268M-
Total Debt9.57M1.24M773%
FUNDAMENTALS RATINGS
MMIRF vs TECX: Fundamental Ratings
MMIRF
TECX
OUTLOOK RATING
1..100
374
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6653
P/E GROWTH RATING
1..100
10068
SEASONALITY SCORE
1..100
7585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MMIRF's Valuation (5) in the null industry is somewhat better than the same rating for TECX (43). This means that MMIRF’s stock grew somewhat faster than TECX’s over the last 12 months.

MMIRF's Profit vs Risk Rating (100) in the null industry is in the same range as TECX (100). This means that MMIRF’s stock grew similarly to TECX’s over the last 12 months.

TECX's SMR Rating (96) in the null industry is in the same range as MMIRF (100). This means that TECX’s stock grew similarly to MMIRF’s over the last 12 months.

TECX's Price Growth Rating (53) in the null industry is in the same range as MMIRF (66). This means that TECX’s stock grew similarly to MMIRF’s over the last 12 months.

TECX's P/E Growth Rating (68) in the null industry is in the same range as MMIRF (100). This means that TECX’s stock grew similarly to MMIRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MMIRFTECX
RSI
ODDS (%)
Bullish Trend 2 days ago
64%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
59%
Bullish Trend 2 days ago
82%
MACD
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
87%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
MMIRF
Daily Signal:
Gain/Loss:
TECX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IPSEF113.13N/A
N/A
Ipsen S.A.
QNTO12.74N/A
N/A
Quaint Oak Bancorp, Inc.
JTCPF17.20N/A
N/A
JTC PLC
TDCSF7.99N/A
N/A
Tdc Software Engineering Inc.
BLMZF0.01N/A
-25.00%
Harrison Global Holdings Inc

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+1.87%
AZTR - MMIRF
24%
Poorly correlated
-4.62%
SRPT - MMIRF
22%
Poorly correlated
-2.12%
SLS - MMIRF
21%
Poorly correlated
+4.79%
More

TECX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TECX has been loosely correlated with IGC. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if TECX jumps, then IGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TECX
1D Price
Change %
TECX100%
+1.87%
IGC - TECX
49%
Loosely correlated
-1.53%
ATHE - TECX
36%
Loosely correlated
-2.87%
IMNM - TECX
36%
Loosely correlated
+3.18%
DNA - TECX
35%
Loosely correlated
-4.04%
SABS - TECX
34%
Loosely correlated
+1.60%
More